Navigation Links
BiOptix to highlight new carbonic anhydrase data at IBC's Biopharmaceutical Development & Production Week
Date:2/27/2013

BOULDER, Colo. and HUNTINGTON BEACH, Calif., Feb. 27, 2013 /PRNewswire/ -- BiOptix is highlighting new and compelling small molecule kinetics data from the new BiOptix 404pi at the IBC Biopharmaceutical Development & Production Week to be held from February 25 – March 1 2013 in Huntington Beach, CA.  These new data sets continue to underscore the versatility of the BiOptix 404pi, an SPR instrument that is built for both protein-protein kinetics as well as protein-small molecule interactions.

"The carbonic anhydrase data from the BiOptix 404pi demonstrate the cornerstone of the BiOptix value proposition:  high sensitivity, low noise and an ability to evaluate small molecule models," noted Ken Wilczek , Vice President of Sales and Marketing for BiOptix.  "Carbonic anhydrase analysis is the gold standard for evaluating SPR instrumentation and the BiOptix 404pi produces excellent data.  BiOptix has designed and built—in the USA—a versatile SPR instrument that is available to the research community at a reasonable price."

Researchers are invited to learn more about the new BiOptix 404pi via the BiOptix Innovators Program—a unique to the industry "try before you buy" SPR instrumentation demo program.  Additional details can be found at:  http://www.bioptix.com/products/innovators-program

Surface Plasmon Resonance is an advanced and highly sensitive optical technology that measures refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.

About BiOptix

BiOptix Diagnostics Corporation is a privately held firm based in Boulder, Colorado, with leading investments from Boulder Ventures and Rusnano.  BiOptix has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR – Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction—with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements. Additional information about BiOptix and our products can be found at:  www.bioptix.com


'/>"/>
SOURCE BiOptix Diagnostics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BiOptix Announces Fall 2012 Tradeshow and Symposia Schedule
2. BiOptix announces expansion of Innovators Program at Molecular Med TRI-CON 2013
3. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
4. Staffing and Performance Benchmarks for Quality Function Highlight New Medical Device Study
5. Isis Reports Financial Results and Highlights for First Quarter 2012
6. Delcath Highlights First Quarter 2012 And Recent Accomplishments
7. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
8. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
9. "Emergency Medical Services Week" Highlights Stroke Survivors and Awareness
10. PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
11. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):